Phytonadione
M.v.i, Phytonadione, Vitamin K1, Vitaped (phytonadione) is a small molecule pharmaceutical. Phytonadione was first approved as Mephyton on 1982-01-01.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Phytonadione, Vitamin k1 (discontinued: Aquamephyton, Konakion, Mephyton, Phytonadione, Vitamin k1)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Phytonadione
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MEPHYTON | Bausch Health Companies | N-010104 DISCN | 1982-01-01 | 1 products, RLD |
| AQUAMEPHYTON | PAI Pharma | N-012223 DISCN | 1982-01-01 | 2 products, RLD |
| KONAKION | Roche | N-011745 DISCN | 1982-01-01 | 2 products |
Hide discontinued
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Phytonadione
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| adult infuvite multiple vitamins | New Drug Application | 2025-08-18 |
| mephyton | New Drug Application | 2020-11-17 |
| pediatric infuvite multiple vitamins | New Drug Application | 2025-08-18 |
| phytonadione | ANDA | 2025-09-08 |
| vitalipid n | unapproved drug for use in drug shortage | 2023-09-07 |
| vitamin k1 | ANDA | 2024-12-06 |
| vitamin k1 - phytonadione | ANDA | 2024-01-30 |
| vitamin k1 phytonadione | ANDA | 2024-01-30 |
Indications
FDA
EMA
Show 18 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| J3430 | Injection, phytonadione (vitamin k), per 1 mg |
Clinical
Clinical Trials
466 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | 2 | 10 | 16 | 19 | 79 | 125 |
| Thrombosis | D013927 | — | — | 1 | 5 | 9 | 7 | 26 | 48 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | 1 | 11 | 8 | 24 | 44 |
| Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | 4 | 10 | 4 | 23 | 39 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 1 | 8 | 4 | 23 | 37 |
| Thromboembolism | D013923 | — | — | — | 1 | 10 | 4 | 20 | 35 |
| Venous thrombosis | D020246 | — | I82.40 | 1 | 5 | 8 | 3 | 13 | 29 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | 1 | 8 | 5 | 10 | 23 |
| Embolism | D004617 | — | — | 1 | — | 4 | 4 | 11 | 20 |
| Calcinosis | D002114 | — | — | — | 2 | 3 | 4 | 7 | 16 |
Show 56 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 4 | 1 | — | 3 | 7 |
| Metabolic bone diseases | D001851 | — | — | 1 | — | 2 | — | 4 | 7 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | 1 | — | 2 | 4 |
| Rheumatic heart disease | D012214 | EFO_1001161 | I09.9 | — | — | 3 | — | 1 | 4 |
| Inflammation | D007249 | MP_0001845 | — | — | — | 1 | — | 3 | 4 |
| Intracranial thrombosis | D020767 | — | — | — | 1 | 1 | — | 1 | 3 |
| Blood coagulation | D001777 | GO_0007596 | — | — | — | 3 | — | — | 3 |
| Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | — | 1 | 2 | — | 1 | 3 |
| Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | — | 1 | — | 1 | 2 |
| Hypertensive intracranial hemorrhage | D020299 | — | — | — | — | 1 | — | 1 | 2 |
Show 22 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 7 | 2 | — | — | 9 | 17 |
| Antiphospholipid syndrome | D016736 | EFO_0002689 | D68.61 | — | 2 | — | — | 4 | 6 |
| Vascular stiffness | D059289 | — | — | — | 1 | — | — | 4 | 5 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 1 | — | — | 2 | 3 |
| Glioblastoma | D005909 | EFO_0000515 | — | 1 | 1 | — | — | — | 2 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | 1 | — | — | — | 2 |
| Pathologic constriction | D003251 | — | — | — | 1 | — | — | 1 | 2 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 1 | — | — | 1 | 2 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 1 | — | — | 1 | 2 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 1 | — | — | 1 | 2 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Arthritis | D001168 | EFO_0005856 | M05-M14 | 3 | — | — | — | 1 | 4 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | 2 | 3 |
| Psoriasis | D011565 | EFO_0000676 | L40 | 3 | — | — | — | — | 3 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 3 | — | — | — | — | 3 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 2 | — | — | — | — | 2 |
| Recurrence | D012008 | — | — | 1 | — | — | — | 1 | 2 |
| Nervous system diseases | D009422 | — | G00-G99 | 1 | — | — | — | 1 | 2 |
| Dysmenorrhea | D004412 | — | N94.6 | 1 | — | — | — | 1 | 2 |
| Eczema | D004485 | — | L30.9 | 1 | — | — | — | 1 | 2 |
| Gliosarcoma | D018316 | — | — | 1 | — | — | — | — | 1 |
Show 18 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ischemic stroke | D000083242 | — | — | — | — | — | — | 7 | 7 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | — | 7 | 7 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 6 | 6 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | — | 6 | 6 |
| Carcinoma | D002277 | — | C80.0 | — | — | — | — | 5 | 5 |
| Vascular diseases | D014652 | EFO_0004264 | I77 | — | — | — | — | 4 | 4 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 4 | 4 |
| Emergencies | D004630 | — | — | — | — | — | — | 3 | 3 |
| Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 3 | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 3 | 3 |
Show 114 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Phytonadione |
| INN | phytomenadione |
| Description | Phylloquinone is a member of the class of phylloquinones that consists of 1,4-naphthoquinone having methyl and phytyl groups at positions 2 and 3 respectively. The parent of the class of phylloquinones. It has a role as a cofactor, a plant metabolite and a human metabolite. It is a vitamin K and a member of phylloquinones. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC1=C(C/C=C(\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O |
Identifiers
| PDB | — |
| CAS-ID | 84-80-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1550 |
| ChEBI ID | 18067 |
| PubChem CID | 5284607 |
| DrugBank | DB01022 |
| UNII ID | S5Z3U87QHF (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Phytonadione – Amphastar Pharmaceuticals
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Phytonadione
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 8,259 documents
View more details
Safety
Black-box Warning
Black-box warning for: Vitamin k1, Vitamin k1 - phytonadione, Vitamin k1 phytonadione
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,902 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use